PRDM1 and lung cancer: A decrease in invasion by A549 lung cancer cells was noted with BLIMP1 siRNA-1, which was even more profound with BLIMP1 siRNA-2 compared to the negative control siRNA, consistent with the migration data (Fig. 1E).